GlassScriptPhysician profile
Robert I Carey
NPI 1831166248
$16,828.55
in general payments reported to CMS, 2019-2025
48 companies · $1,655 in 2025
The $1,655 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,247 · 2020: $614 · 2021: $517 · 2022: $978 · 2023: $7,197 · 2024: $4,620 · 2025: $1,655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,653 · Food and Beverage: $4,467 · Travel and Lodging: $1,216 · Debt Forgiveness: $749 · Education: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,653.00 |
| Food and Beverage | $4,467.44 |
| Travel and Lodging | $1,215.92 |
| Debt Forgiveness | $748.60 |
| Education | $386.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $2,943.89 | 2019-2025 | Adstiladrin, Firmagon |
| Astellas Pharma Global Development | $1,755.00 | 2023 | Xtandi |
| Profound Medical Corp. | $1,575.07 | 2024-2025 | Tulsa-Pro |
| Janssen Global Services, LLC | $1,410.00 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $1,382.03 | 2022-2025 | |
| Astellas Pharma US INC | $1,170.71 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $999.27 | 2019-2025 | Erleada |
| Olympus America INC. | $940.20 | 2020-2024 | Cysto-Nephro Videoscope, Itind System |
| Boston Scientific Corporation | $768.54 | 2019-2025 | Lithovue, Lithovue Empower, Spaceoar System |
| Intuitive Surgical, INC. | $580.55 | 2020-2022 | |
| Abbvie INC. | $555.12 | 2019-2025 | Botox, Lupron Depot |
| Pfizer INC. | $339.33 | 2019-2025 | |
| Dornier Medtech America, INC | $238.35 | 2025 | Dornier Medtech |
| Sumitomo Pharma America, INC. | $192.10 | 2023-2025 | Orgovyx, Gemtesa |
| Novartis Pharmaceuticals Corporation | $179.93 | 2022-2025 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $149.08 | 2023-2025 | Erleada, Pipeline |
| Procept Biorobotics Corporation | $144.82 | 2022-2024 | Aquabeam System |
| Merck Sharp & Dohme LLC | $136.72 | 2022-2025 | Lynparza, Keytruda, Welireg |
| Angiodynamics, INC. | $123.49 | 2024 | Nanoknife |
| Coloplast Corp | $109.46 | 2022-2024 | |
| Urogen Pharma, INC. | $106.83 | 2022-2025 | Jelmyto |
| Allergan, INC. | $86.81 | 2019-2021 | |
| Teleflex LLC | $84.43 | 2023-2025 | Urolift, Barrigel |
| Antares Pharma, INC. | $77.43 | 2019-2023 | Xyosted, Tlando, Nocdurna |
| Endo Pharmaceuticals INC. | $73.64 | 2023-2024 | Xiaflex, Aveed, Edex |
| Myovant Sciences INC. | $72.68 | 2021-2022 | |
| Tolmar, INC. | $65.85 | 2023-2025 | Eligard |
| Laborie Medical Technologies Corp. | $57.12 | 2022-2025 | |
| Tolmar Pharmaceuticals, INC. | $55.41 | 2022 | |
| Endo USA, INC. | $55.22 | 2024-2025 | Xiaflex, Edex |
| C. R. Bard, INC. & Subsidiaries | $45.97 | 2019-2022 | |
| Medtronic, INC. | $42.69 | 2022 | |
| Axonics, INC. | $35.83 | 2023-2024 | Axonics, Bulkamid |
| Sun Pharmaceutical Industries INC. | $28.15 | 2024 | |
| Ethicon US, LLC | $24.76 | 2025 | Harmonic |
| Urovant Sciences INC | $23.15 | 2022 | |
| Accord Healthcare, INC. | $23.05 | 2025 | |
| Smith+Nephew, INC. | $22.37 | 2019 | |
| Telix Pharmaceuticals | $20.27 | 2023 | Illuccix |
| 180 Medical, INC. | $20.22 | 2024 | Gentlecath |
| Astrazeneca Pharmaceuticals LP | $18.39 | 2020 | |
| Travere Therapeutics, INC. | $17.68 | 2019 | |
| Blue Earth Diagnostics | $17.23 | 2023 | |
| Dendreon Pharmaceuticals LLC | $16.60 | 2021 | |
| Baxter Healthcare | $15.41 | 2019 | |
| Amgen INC. | $13.93 | 2019 | |
| Therapeuticsmd, INC. | $13.77 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Carey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.